Novavax is Newest Vaccine Company On The Block, Headed To The FDA For Approval
COVid Vaccine - istock

Biden Administration Reaches 200 Million COVID-19 Vaccine Goal Early

President Joe Biden set a goal of putting 200 million doses of the COVID-19 vaccine into Americans’ arms in his administration’s first 100 days. He reached that goal by the end of the day Wednesday, the 92nd day of his presidency.

“Today, we did it, today we hit 200 million shots in the 92nd day in office,” the president said in a prepared statement. “This is an American achievement, a powerful demonstration of unity and resolve — what unity will do for us, and a reminder of what we can accomplish when we pull together, as one people, to a common goal.”

According to ABC News, Biden initially set the goal at 100 million doses, but when he reached that on day 58, he doubled itThe total does not include 13 million shots administered during the end of Trump’s presidency.

Biden also highlighted a paid leave tax credit for businesses to cover employees’ time off to receive a vaccine or recover from side effects on Wednesday. The credits are for small businesses — companies with less than 500 employees — and provide up to $500 per employee per day. The tax credit was included in Biden’s $1.9 trillion coronavirus relief package.

“No working American should lose a single dollar from their paycheck because they chose to fulfill their patriotic duty of getting vaccinated,” President Biden said.

author avatar
ErinBoogie
Erin Boogie is a blogger for BallerAlert.com and producer/co-host of the weekly radio show In the Field Radio.

About ErinBoogie

Erin Boogie is a blogger for BallerAlert.com and producer/co-host of the weekly radio show In the Field Radio.

Check Also

How GloRilla Narrowly Avoided A Hate Train & Bounced Back Harder Than Ever

GloRilla’s DUI Arrest and Wardrobe Mishap in Gwinnett County

Rapper GloRilla found herself in some legal trouble earlier this week, following an early morning …

Leave a Reply

Discover more from Baller Alert

Subscribe now to keep reading and get access to the full archive.

Continue reading